Logo image of MDV

MODIV INDUSTRIAL INC (MDV) Stock Fundamental Analysis

NYSE:MDV - New York Stock Exchange, Inc. - US60784B1017 - REIT - Currency: USD

14.9  -0.74 (-4.73%)

Fundamental Rating

4

MDV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 129 industry peers in the Diversified REITs industry. MDV has only an average score on both its financial health and profitability. MDV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

MDV had positive earnings in the past year.
MDV had a positive operating cash flow in the past year.
In the past 5 years MDV always reported negative net income.
Of the past 5 years MDV 4 years had a positive operating cash flow.
MDV Yearly Net Income VS EBIT VS OCF VS FCFMDV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M -80M -100M

1.2 Ratios

The Return On Assets of MDV (-0.10%) is worse than 61.24% of its industry peers.
MDV's Return On Equity of -0.28% is on the low side compared to the rest of the industry. MDV is outperformed by 61.24% of its industry peers.
MDV has a Return On Invested Capital (2.83%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for MDV is in line with the industry average of 3.17%.
The 3 year average ROIC (1.33%) for MDV is below the current ROIC(2.83%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.1%
ROE -0.28%
ROIC 2.83%
ROA(3y)-1.28%
ROA(5y)-3.36%
ROE(3y)-4.12%
ROE(5y)-9.95%
ROIC(3y)1.33%
ROIC(5y)1.07%
MDV Yearly ROA, ROE, ROICMDV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 -10 -20 -30

1.3 Margins

MDV's Operating Margin of 37.87% is amongst the best of the industry. MDV outperforms 83.72% of its industry peers.
MDV's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 92.74%, MDV belongs to the top of the industry, outperforming 94.57% of the companies in the same industry.
MDV's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 37.87%
PM (TTM) N/A
GM 92.74%
OM growth 3Y26.38%
OM growth 5Y-1.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.82%
GM growth 5Y1.58%
MDV Yearly Profit, Operating, Gross MarginsMDV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MDV is destroying value.
MDV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MDV Yearly Shares OutstandingMDV Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
MDV Yearly Total Debt VS Total AssetsMDV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

MDV has an Altman-Z score of 0.13. This is a bad value and indicates that MDV is not financially healthy and even has some risk of bankruptcy.
MDV's Altman-Z score of 0.13 is on the low side compared to the rest of the industry. MDV is outperformed by 70.54% of its industry peers.
MDV has a debt to FCF ratio of 33.91. This is a negative value and a sign of low solvency as MDV would need 33.91 years to pay back of all of its debts.
The Debt to FCF ratio of MDV (33.91) is better than 63.57% of its industry peers.
MDV has a Debt/Equity ratio of 1.50. This is a high value indicating a heavy dependency on external financing.
MDV has a worse Debt to Equity ratio (1.50) than 62.02% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.5
Debt/FCF 33.91
Altman-Z 0.13
ROIC/WACC0.4
WACC6.99%
MDV Yearly LT Debt VS Equity VS FCFMDV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

2.3 Liquidity

A Current Ratio of 3.97 indicates that MDV has no problem at all paying its short term obligations.
The Current ratio of MDV (3.97) is better than 93.80% of its industry peers.
MDV has a Quick Ratio of 3.97. This indicates that MDV is financially healthy and has no problem in meeting its short term obligations.
MDV has a better Quick ratio (3.97) than 93.80% of its industry peers.
Industry RankSector Rank
Current Ratio 3.97
Quick Ratio 3.97
MDV Yearly Current Assets VS Current LiabilitesMDV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 114.97% over the past year.
EPS 1Y (TTM)114.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%115.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-4.55%

3.2 Future

MDV is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -19.32% yearly.
Based on estimates for the next years, MDV will show a small growth in Revenue. The Revenue will grow by 2.06% on average per year.
EPS Next Y-144.44%
EPS Next 2Y-65.19%
EPS Next 3Y-19.32%
EPS Next 5YN/A
Revenue Next Year3.99%
Revenue Next 2Y5.52%
Revenue Next 3Y2.06%
Revenue Next 5YN/A

3.3 Evolution

MDV Yearly Revenue VS EstimatesMDV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
MDV Yearly EPS VS EstimatesMDV Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

MDV is valuated quite expensively with a Price/Earnings ratio of 59.60.
Based on the Price/Earnings ratio, MDV is valued a bit more expensive than 62.79% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.10, MDV is valued quite expensively.
MDV is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 59.6
Fwd PE N/A
MDV Price Earnings VS Forward Price EarningsMDV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 100 -100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MDV is valued a bit cheaper than 65.12% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MDV indicates a somewhat cheap valuation: MDV is cheaper than 75.97% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 18.01
EV/EBITDA 12.43
MDV Per share dataMDV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A cheap valuation may be justified as MDV's earnings are expected to decrease with -19.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-65.19%
EPS Next 3Y-19.32%

More info and screens

4

5. Dividend

5.1 Amount

MDV has a Yearly Dividend Yield of 7.11%, which is a nice return.
MDV's Dividend Yield is a higher than the industry average which is at 6.64.
MDV's Dividend Yield is rather good when compared to the S&P500 average which is at 2.43.
Industry RankSector Rank
Dividend Yield 7.11%

5.2 History

MDV has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years2
MDV Yearly Dividends per shareMDV Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

MDV has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-2613.64%
EPS Next 2Y-65.19%
EPS Next 3Y-19.32%
MDV Yearly Income VS Free CF VS DividendMDV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M -80M -100M

More info and screens

MODIV INDUSTRIAL INC

NYSE:MDV (5/6/2025, 3:13:38 PM)

14.9

-0.74 (-4.73%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)03-04 2025-03-04/bmo
Earnings (Next)05-19 2025-05-19/bmo
Inst Owners15.42%
Inst Owner Change0.01%
Ins Owners3.19%
Ins Owner Change1.34%
Market Cap148.55M
Analysts84.44
Price Target18.36 (23.22%)
Short Float %0.23%
Short Ratio0.48
Dividend
Industry RankSector Rank
Dividend Yield 7.11%
Yearly Dividend1.56
Dividend Growth(5Y)N/A
DP-2613.64%
Div Incr Years1
Div Non Decr Years2
Ex-Date06-30 2025-06-30 (0.0975)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-267.33%
Min EPS beat(2)-694.06%
Max EPS beat(2)159.41%
EPS beat(4)2
Avg EPS beat(4)-290.92%
Min EPS beat(4)-1618.15%
Max EPS beat(4)989.11%
EPS beat(8)4
Avg EPS beat(8)-12.09%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.51%
Min Revenue beat(2)-4.05%
Max Revenue beat(2)1.02%
Revenue beat(4)1
Avg Revenue beat(4)-1.93%
Min Revenue beat(4)-4.05%
Max Revenue beat(4)1.02%
Revenue beat(8)4
Avg Revenue beat(8)5.66%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.92%
PT rev (3m)-0.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 59.6
Fwd PE N/A
P/S 3.14
P/FCF 18.01
P/OCF 8.16
P/B 0.8
P/tB 0.8
EV/EBITDA 12.43
EPS(TTM)0.25
EY1.68%
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)0.83
FCFY5.55%
OCF(TTM)1.83
OCFY12.25%
SpS4.75
BVpS18.68
TBVpS18.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.1%
ROE -0.28%
ROCE 3.58%
ROIC 2.83%
ROICexc 2.87%
ROICexgc 2.88%
OM 37.87%
PM (TTM) N/A
GM 92.74%
FCFM 17.43%
ROA(3y)-1.28%
ROA(5y)-3.36%
ROE(3y)-4.12%
ROE(5y)-9.95%
ROIC(3y)1.33%
ROIC(5y)1.07%
ROICexc(3y)1.38%
ROICexc(5y)1.11%
ROICexgc(3y)1.41%
ROICexgc(5y)1.15%
ROCE(3y)1.69%
ROCE(5y)1.37%
ROICexcg growth 3Y20.93%
ROICexcg growth 5Y2.23%
ROICexc growth 3Y23.09%
ROICexc growth 5Y2.13%
OM growth 3Y26.38%
OM growth 5Y-1.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.82%
GM growth 5Y1.58%
F-Score6
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 1.5
Debt/FCF 33.91
Debt/EBITDA 8.11
Cap/Depr 60.01%
Cap/Sales 21.04%
Interest Coverage 1.34
Cash Conversion 52.75%
Profit Quality N/A
Current Ratio 3.97
Quick Ratio 3.97
Altman-Z 0.13
F-Score6
WACC6.99%
ROIC/WACC0.4
Cap/Depr(3y)603.42%
Cap/Depr(5y)417.25%
Cap/Sales(3y)200.21%
Cap/Sales(5y)142.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)114.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%115.22%
EPS Next Y-144.44%
EPS Next 2Y-65.19%
EPS Next 3Y-19.32%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-4.55%
Revenue Next Year3.99%
Revenue Next 2Y5.52%
Revenue Next 3Y2.06%
Revenue Next 5YN/A
EBIT growth 1Y78.47%
EBIT growth 3Y34.85%
EBIT growth 5Y18.96%
EBIT Next Year939.49%
EBIT Next 3Y128.06%
EBIT Next 5Y92.43%
FCF growth 1Y106.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y42.77%
OCF growth 3Y43.76%
OCF growth 5Y23.04%